Alessandro Costa

Cagliari, 09121, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 52 publications

Targeting the hepcidin-ferroportin axis in polycythemia vera: a complementary approach to clone-directed therapies.

Targeting the hepcidin-ferroportin axis in polycythemia vera: a complementary approach to clone-directed therapies.

Journal: Blood reviews

Published: June 13, 2026

Estimated pulse wave velocity as a marker of major adverse cardiovascular events in essential thrombocythaemia and polycythaemia vera.

Estimated pulse wave velocity as a marker of major adverse cardiovascular events in essential thrombocythaemia and polycythaemia vera.

Journal: British journal of haematology

Published: June 09, 2026

Hepcidin as a Molecular Hub of Iron Homeostasis: From BMP-SMAD Signaling to Therapeutic Modulation.

Hepcidin as a Molecular Hub of Iron Homeostasis: From BMP-SMAD Signaling to Therapeutic Modulation.

Journal: Biomolecules

Published: May 29, 2026

Arterial stiffness in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors: An exploratory prospective observational study.

Arterial stiffness in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors: An exploratory prospective observational study.

Journal: Leukemia research

Published: May 22, 2026

Prophylaxis and management of thromboembolism in pnh patients: an italian survey.

Prophylaxis and management of thromboembolism in pnh patients: an italian survey.

Journal: Annals of hematology

Published: February 03, 2026

Gaucher disease: the hematologist's perspective of a multisystemic disorder.

Gaucher disease: the hematologist's perspective of a multisystemic disorder.

Journal: Annals of hematology

Published: January 27, 2026

Advances of next-generation STAMP inhibitors in chronic myeloid leukemia.

Advances of next-generation STAMP inhibitors in chronic myeloid leukemia.

Journal: Expert opinion on investigational drugs

Published: January 21, 2026

Very long-term outcomes of chronic-phase chronic myeloid leukaemia patients treated with imatinib: A 25-year real-world cohort study.

Very long-term outcomes of chronic-phase chronic myeloid leukaemia patients treated with imatinib: A 25-year real-world cohort study.

Journal: British journal of haematology

Published: December 19, 2025

Clinical and prognostic significance of concomitant autoimmune disease in patients with myelofibrosis.

Clinical and prognostic significance of concomitant autoimmune disease in patients with myelofibrosis.

Journal: Annals of hematology

Published: November 29, 2025

Challenges in the Evolving Role of Calreticulin as a Promising Target for Precision Medicine in Myeloproliferative Neoplasms.

Challenges in the Evolving Role of Calreticulin as a Promising Target for Precision Medicine in Myeloproliferative Neoplasms.

Journal: Cancers

Published: September 25, 2025

Health-related quality of life and symptom profile of patients with BCR::ABL1-negative myeloproliferative neoplasms: Real-world evidence from the GIMEMA-PROPHECY observational study.

Health-related quality of life and symptom profile of patients with BCR::ABL1-negative myeloproliferative neoplasms: Real-world evidence from the GIMEMA-PROPHECY observational study.

Journal: HemaSphere

Published: August 05, 2025

Outpatient Versus Inpatient Azacitidine Plus Venetoclax Regimen in Elderly Acute Myeloid Leukemia: A Multicenter Retrospective Analysis.

Outpatient Versus Inpatient Azacitidine Plus Venetoclax Regimen in Elderly Acute Myeloid Leukemia: A Multicenter Retrospective Analysis.

Journal: European journal of haematology

Published: July 23, 2025

Showing 1-12 of 52

Last Updated: 09/26/2026